Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2025-10-16
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation Study in Patients of a Non-invasive Blood Pressure Monitor for Perioperative Use
NCT03795831
Non-Invasive Blood Pressure Monitoring
NCT05825937
ClearSight System CHN Study
NCT03807622
Noninvasive Beat-to-Beat ClearSight Blood Pressure Monitoring
NCT02872896
A Study to Demonstrate the Clinical Accuracy of the Smartphone Vital Signs System (SVSS)
NCT02199457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult OR patients with planned or existing arterial blood pressure monitoring
ClearSight NextGen system
Study devices will be applied to subjects for monitoring for the duration of the procedure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ClearSight NextGen system
Study devices will be applied to subjects for monitoring for the duration of the procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age ≥ 18 years
3. Planned or existing monitoring with an arterial catheter as part of standard of care
4. Patient scheduled to undergo surgery with general anesthesia lasting \> 2 hours
Exclusion Criteria
2. Known left-right difference in blood pressure
3. Extreme contraction of the smooth muscles in the arteries and arterioles of the lower arm and hand, such as may be present in patients with Raynaud's disease
4. Patients deemed not suitable for the study at the discretion of the Investigator
5. Participation in another study that clinically interferes with the current study
6. Treatment with an intra-aortic balloon pump
7. Pregnancy
8. Cardiac surgery including bypass period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
York Teaching Hospitals NHS Foundation Trust
York, England, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.